Product Details
Onbrez Breezhaler
Indacaterol75 mcg
Powder for Inhalation
Capsule
DIN/PIN/NPN
02376938
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2013-04-30
Unit Price
1.5500
Amount MOH Pays
1.5500
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
R03AC18
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 443 | Indefinite | For patients with moderate to severe COPD with persistent respiratory symptoms despite an adequate trial of, or an intolerance to, a regularly scheduled short-acting bronchodilator AND a long-acting anticholinergic. Note: The dose of Onbrez Breezhaler should not exceed 75mcg per day. |